Cargando…
The Different Mechanisms of Cancer Drug Resistance: A Brief Review
Anticancer drugs resistance is a complex process that arises from altering in the drug targets. Advances in the DNA microarray, proteomics technology and the development of targeted therapies provide the new strategies to overcome the drug resistance. Although a design of the new chemotherapy agents...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Tabriz University of Medical Sciences
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5651054/ https://www.ncbi.nlm.nih.gov/pubmed/29071215 http://dx.doi.org/10.15171/apb.2017.041 |
_version_ | 1783272819266682880 |
---|---|
author | Mansoori, Behzad Mohammadi, Ali Davudian, Sadaf Shirjang, Solmaz Baradaran, Behzad |
author_facet | Mansoori, Behzad Mohammadi, Ali Davudian, Sadaf Shirjang, Solmaz Baradaran, Behzad |
author_sort | Mansoori, Behzad |
collection | PubMed |
description | Anticancer drugs resistance is a complex process that arises from altering in the drug targets. Advances in the DNA microarray, proteomics technology and the development of targeted therapies provide the new strategies to overcome the drug resistance. Although a design of the new chemotherapy agents is growing quickly, effective chemotherapy agent has not been discovered against the advanced stage of cancer (such as invasion and metastasis). The cancer cell resistance against the anticancer agents can be due to many factors such as the individual’s genetic differences, especially in tumoral somatic cells. Also, the cancer drug resistance is acquired, the drug resistance can be occurred by different mechanisms, including multi-drug resistance, cell death inhibiting (apoptosis suppression), altering in the drug metabolism, epigenetic and drug targets, enhancing DNA repair and gene amplification. In this review, we outlined the mechanisms of cancer drug resistance and in following, the treatment failures by common chemotherapy agents in the different type of cancers. |
format | Online Article Text |
id | pubmed-5651054 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Tabriz University of Medical Sciences |
record_format | MEDLINE/PubMed |
spelling | pubmed-56510542017-10-25 The Different Mechanisms of Cancer Drug Resistance: A Brief Review Mansoori, Behzad Mohammadi, Ali Davudian, Sadaf Shirjang, Solmaz Baradaran, Behzad Adv Pharm Bull Review Article Anticancer drugs resistance is a complex process that arises from altering in the drug targets. Advances in the DNA microarray, proteomics technology and the development of targeted therapies provide the new strategies to overcome the drug resistance. Although a design of the new chemotherapy agents is growing quickly, effective chemotherapy agent has not been discovered against the advanced stage of cancer (such as invasion and metastasis). The cancer cell resistance against the anticancer agents can be due to many factors such as the individual’s genetic differences, especially in tumoral somatic cells. Also, the cancer drug resistance is acquired, the drug resistance can be occurred by different mechanisms, including multi-drug resistance, cell death inhibiting (apoptosis suppression), altering in the drug metabolism, epigenetic and drug targets, enhancing DNA repair and gene amplification. In this review, we outlined the mechanisms of cancer drug resistance and in following, the treatment failures by common chemotherapy agents in the different type of cancers. Tabriz University of Medical Sciences 2017-09 2017-09-25 /pmc/articles/PMC5651054/ /pubmed/29071215 http://dx.doi.org/10.15171/apb.2017.041 Text en ©2017 The Authors. http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution (CC BY), which permits unrestricted use, distribution, and reproduction in any medium, as long as the original authors and source are cited. No permission is required from the authors or the publishers. |
spellingShingle | Review Article Mansoori, Behzad Mohammadi, Ali Davudian, Sadaf Shirjang, Solmaz Baradaran, Behzad The Different Mechanisms of Cancer Drug Resistance: A Brief Review |
title |
The Different Mechanisms of Cancer Drug Resistance: A Brief Review
|
title_full |
The Different Mechanisms of Cancer Drug Resistance: A Brief Review
|
title_fullStr |
The Different Mechanisms of Cancer Drug Resistance: A Brief Review
|
title_full_unstemmed |
The Different Mechanisms of Cancer Drug Resistance: A Brief Review
|
title_short |
The Different Mechanisms of Cancer Drug Resistance: A Brief Review
|
title_sort | different mechanisms of cancer drug resistance: a brief review |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5651054/ https://www.ncbi.nlm.nih.gov/pubmed/29071215 http://dx.doi.org/10.15171/apb.2017.041 |
work_keys_str_mv | AT mansooribehzad thedifferentmechanismsofcancerdrugresistanceabriefreview AT mohammadiali thedifferentmechanismsofcancerdrugresistanceabriefreview AT davudiansadaf thedifferentmechanismsofcancerdrugresistanceabriefreview AT shirjangsolmaz thedifferentmechanismsofcancerdrugresistanceabriefreview AT baradaranbehzad thedifferentmechanismsofcancerdrugresistanceabriefreview AT mansooribehzad differentmechanismsofcancerdrugresistanceabriefreview AT mohammadiali differentmechanismsofcancerdrugresistanceabriefreview AT davudiansadaf differentmechanismsofcancerdrugresistanceabriefreview AT shirjangsolmaz differentmechanismsofcancerdrugresistanceabriefreview AT baradaranbehzad differentmechanismsofcancerdrugresistanceabriefreview |